Aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants

Clicks: 377
ID: 112207
1996
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Aerosolized immunoglobulin in the dosage used had no substantial beneficial effect on RSV bronchiolitis. Despite these findings passive immunotherapy for treatment of RSV-induced lower respiratory tract infection deserves further evaluation before being discarded as ineffective.
Reference Key
pc1996theaerosolized Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Rimensberger PC;Burek-Kozlowska A;Morell A;Germann D;Eigenmann AK;Steiner F;Burger R;Kuenzli M;Schaad UB;;
Journal the pediatric infectious disease journal
Year 1996
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8852908
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE animals humans pubmed abstract nih national institutes of health national library of medicine Infant newborn Clinical Trial Randomized Controlled Trial Antibodies Multicenter Study Antigens Viral / analysis respiratory syncytial virus infections / immunology respiratory syncytial viruses / isolation & purification aerosols respiratory syncytial virus infections / drug therapy* respiratory syncytial viruses / immunology p c rimensberger u b schaad pmid:8852908 doi:10.1097/00006454-199603000-00007 a burek-kozlowska viral / pharmacology* chlorocebus aethiops immunoglobulins / pharmacology* respiratory syncytial virus infections / virology respiratory syncytial viruses / classification respiratory syncytial viruses / drug effects* vero cells

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.